Fresenius Kabi Further Expands Radiology Portfolio with Launch of Gadobutrol Injection

LAKE ZURICH, Ill.–(BUSINESS WIRE)– #FreseniusKabi–Fresenius Kabi announced today it has launched Gadobutrol Injection, a generic substitute for the contrast agent Gadavist®, which is used in magnetic resonance imaging (MRI) procedures. Fresenius Kabi Gadobutrol Injection, a high-relaxivity macrocyclic agent, is available immediately in the United States. It is the second MRI…
Click here to view original post